Global Fertilty Services Market 2016-2020

About Fertility Services

Couples with fertility issues are unable to conceive even after regular unprotected coitus. Infertility complications are widespread, with either female or male infertility factors accounting for one-third of the cases. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.

Technavio’s analysts forecast the global fertility services market to grow at a CAGR of 8.72% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global fertility services market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of infertility drugs and assisted reproductive technology (ART).

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

Technavio's report, Global Fertility Services Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Carefertility
• Coopersurgical
• Ferring Pharmaceuticals
• Merck
• MonashIVF
• Vitrolife

Other prominent vendors

• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Auxogyn
• Bristol-Myers Squibb
• Cell Cura
• Dong-A Socio
• Elelixis Diagnostics
• Eli Lilly
• EMD Serono
• Fertility Focus
• Halotech
• HRA Pharma
• IKS International
• In Vitro Care
• Invo Bioscience
• Irvine Scientific
• IVFtech Aps
• Kitazato
• Life Global
• Medical Electronic Systems
• Meditex
• Microtech IVF
• Nidacon International
• Novartis
• NuSep
• Ovascience
• Pantec Biosolutions
• Pfizer
• PregLem
• Reproductive Health Science
• ReproTech
• Sanofi
• Smiths Medical International
• Sperm Processor
• Vitrolife
• Vivus
• Xytex Cryo International.

Market driver

• Increase in infertility rate and obesity
• For a full, detailed list, view our report

Market challenge

• High cost of fertility treatment
• For a full, detailed list, view our report

Market trend

• Increase in R&D
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Press Release

Technavio Announces the Publication of its Research Report – Global Fertility Services Market 2016-2020

Technavio recognizes the following companies as the key players in the Global Fertility Services Market: Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, and Vitrolife.

Other Prominent Vendors in the market are: Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, and Xytex Cryo International.

Commenting on the report, an analyst from Technavio’s team said: “The rising demand for fertility services will require an increase in the volume of supply. Governments of various countries are establishing new fertility clinics to manage the demand for fertility services. Vendors are conducting R&D to further improve the technology of available fertility services and develop innovative techniques.”

According to the report, with aging, the human body undergoes various physiological and hormonal changes that can contribute to problems related to fertility. Medical studies by different research institutes state that women aged 35 years and above face various complications related to fertility. These studies estimate that women in this age group have an infertility rate of over 35%. Aging causes decreased sperm motility in men. The presence of obesity adds to fertility complications in both men and women. Obesity is a known cause of infertility, as it leads to problems with ovulation and low sperm count.

Further, the report states that the cost of fertility services is high in the US compared to countries such as India, Taiwan, and Hong Kong. Fertility services can lead to multiple pregnancies, internal bleeding or infection, and congenital defects. Costs related to the treatment of these complications can further increase the overall costs for people undergoing fertility services.

Companies Mentioned

Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, Vitrolife, Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, Xytex Cryo International.